Skip Navigation

Instructions to Authors

All papers in Molecular Plant are available free of charge to all readers during 2007 and 2008

No page or colour charges for Molecular Plant authors during 2007 or 2008


Authors who are NIH-funded will have their papers automatically deposited in PubMed Central.

Aims and Scope
Manuscript Submission
Authorship
Manuscript preparation and organisation
Figures
Nomenclature and terminology
Cover Submissions
Peer Review
Manuscript Acceptance
Proofs
Fees and Charges
Reprints
Policies
Funding

Aims and Scope

Molecular Plant is a new, top-tier, fast turnaround international journal that publishes significant findings in plant biology, focusing broadly on cellular biology, physiology, molecular biology, genetics, development, and evolution.

In addition to full papers with novel insights of high impact, we particularly encourage submissions of original research that is highly novel but not fully-developed. Contributions may comprise Research Articles, Review Articles, Technical Breakthroughs, Editorials and Commentaries, most of which will be organized into 'Current Topics' in the first phase of the journal publication.

Manuscript Submission

Before initiating the submission process, the instructions below should be read carefully to ensure that the article complies with Molecular Plant standards. Even if authors have previously read them, it is strongly recommended that these pages be reread in their entirety, as they are updated periodically.

Authors should submit manuscripts online at
http://submit.mplant.oxfordjournals.org/. The Bench>Press submission system will prompt authors through the process. Help is also available from http://submit.mplant.oxfordjournals.org/submission/submissionhelp and from the editorial office (Tel: +86 21-54922858 or +1 415 338-6193; Email: staff-mplant@sibs.ac.cn). For manuscript submission, a manuscript file in Microsoft Word (or some other word processing form) is required and will be automatically converted to a PDF by the Bench>Press submission system. Alternatively, authors may create and submit their own PDF which will not be subjected to any conversion. Although there are no file size limitations, note that large files will take longer to upload and convert to PDF depending on the Internet connection. Please try to keep the maximum combined PDF file size to less than 5 MB.

If you are not satisfied with the final conversion results when the submission is proofed, the complete manuscript can be reloaded as a PDF file.

Manuscript Preparation and Organisation

Manuscripts should follow Molecular Plant style, be written in concise and grammatically correct English, and be presented in a manner and at a level that will be accessible to the broad readership of the journal, not specialists. The use of abbreviations and jargon should be avoided, and terms that are not widely known should be explained clearly at first use.

Consult a current issue of Molecular Plant for guidance on format, organization, and preparation of figures, legends, tables, and references. In general, there are no limits to the length of manuscripts published in Molecular Plant; however, the editors may request shortening of papers they deem unnecessarily long. Manuscripts should be prepared in Microsoft Word with 1.5 line spacing and in 12 point type; use symbol font for Greek characters to avoid inadvertent character substitutions. Please do not use Chinese, Japanese or Korean fonts. Figures should be prepared digitally (see below).

Formats accepted for the manuscript file are Word, WordPerfect, and PDF (Portable Document File). For Word processing files, Times, Times New Roman, Courier, Helvetica and Arial are the recommended fonts; for best quality conversions of special characters and symbols, use the Symbol font. Image and table file formats accepted are GIF, TIFF, EPS and JPEG. For tables, the system also accepts the most common word processing formats. Formats not supported include the following: Bitmap (.bmp), PICT (.pict), Excel (.xls), Photoshop (.psd), Canvas (.cnv), CorelDRAW (.cdr) and locked or encrypted PDFs. Multi-page PowerPoint files (.ppt) are not supported; one slide per file is acceptable.

Organize manuscripts in the following order: Title Page, Abstract, Introduction, Results, Discussion, Methods, Acknowledgments, Figure Legends, Tables, and References. Note that when submitting your manuscript the References must be placed at the end of your document file. Tables should be included as part of your manuscript file. Figures and regular Supplementary data (Supplementary text, figures and small tables) should be sent as separate files and not as part of the manuscript. See the sections on Figures and Supplementary Data below for more details.

Corresponding authors must declare if they or their co-authors have any conflicts of interest to declare, and to provide details of these by submitting a completed Conflict of Interest form to the Editorial Office. If the Corresponding author is unable to confirm this information on behalf of all co-authors, the authors in question will then be required to submit a completed Conflict of Interest form. It is the Corresponding author’s responsibility to ensure that all authors adhere to this policy.

If the manuscript is published, Conflict of Interest information will be communicated in a statement in the published paper. Please note that your submission must be accompanied by a Conflict of Interest form.

Title Page
The title page should include the authors' full names and affiliations, a running title of 50 characters or less (in addition to the full paper title), and the telephone and fax numbers and e-mail address of the corresponding author, who will be designated in the online submission system to be the primary contact with the journal office. Institutional affiliations should correspond to where the work was done, not where the author is at present.

Manuscript Title
The full manuscript title should be succinct (approximately 120 characters and informative. The title should include sufficient detail for indexing but be general enough to be clear to the broad readership of the journal. Toward that end, abbreviations and acronyms, including those for gene and protein names, should be avoided in titles or the general nature of the abbreviated entity should be clear. The journal encourages active titles over merely descriptive ones whenever possible. The title must mention the subject organism (or general group in the case of comparative works). Common names are allowed for major model systems (maize, rice, yeast); scientific names should be used for all organisms that have no widely accepted common name.

Abstract
The abstract should stand on its own with no reference to the text. It should contain approximately 200 words and must summarize the questions being addressed, the approach taken, the major findings, and the significance of the results. It should not contain discursive matter. The abstract should be concise, complete, and clearly communicate the importance of the work for a broad audience.

Introduction
The Introduction should provide the necessary background information for the average reader; it should be both complete and concise. Previous publications that form a basis for the work presented must be cited. Citation of reviews is not a substitute for citing primary research articles. Citation of recent research articles is not a substitute for citing original discoveries. An author's own work should not be cited preferentially over equally relevant work of others. Authors' previously published data that are presented along with new data must be identified clearly and cited appropriately; duplicate publication of data (including data previously published as supplementary material) is not allowed without citation.

Results and Discussion
The Results and Discussion can be subdivided if subheadings give the manuscript more clarity. The Discussion should not repeat the Results; instead, the Discussion should explore the implications of the Results, citing relevant published research, and should also be as concise as possible.

Conclusions
A Conclusions section is generally not permitted. Statements of priority or first finding are generally not permitted in Molecular Plant.

Methods
Methods must be described completely enough that other laboratories can replicate results and verify claims. Generally, standard procedures should be referenced, though significant variations should be described. Appropriate experimental design and statistical methods should be applied and described wherever necessary for proper interpretation of data and verification of claims. All novel materials and the procedures to prepare them should be described in sufficient detail to allow their reproduction (e.g., DNA constructs, genetic stocks, enzyme preparations, and analytical software). Publication in Molecular Plant requires that authors make available all novel materials integral to the reported results for non-commercial research purposes (see Materials Distribution Policy [link 3]). A statement concerning the availability, or restrictions on availability, should be included in the Methods section of the paper; it will be up to referees to decide if any such restrictions are reasonable.

Large-scale experiments. In evaluating large-scale experiments such as transcript profiling, we will consider whether there is a clear and complete description of each experiment; whether biological and/or technical replicates should have been used; what statistical analysis has been performed. Large-scale data sets must be made available for review at the time of submission and must be deposited in an accepted format to a permanent public repository with open access (e.g., GEO http://www.ncbi.nlm.nih.gov or Array-Express http://www.ebi.ac.uk/arrayexpress.

Quantification of molecules, including DNA, RNA, and proteins. Methods for quantification of levels or differences in levels of molecules in biological samples must be described fully and shown to be quantitative and reproducible, using true biological replicates. Any conclusion that levels differ between samples must be supported by presentation of methods and data shown to be reliable; supporting information demonstrating reliability of an assay may sometimes be provided as Supplementary Information rather than in the body of the manuscript, subject to the approval of the handling editor. Use of the term ‘semi-quantitative’ is not acceptable in Molecular Plant; instead, assays must be shown to be sufficiently quantitative to support a conclusion of changes in levels.

Molecular phylogenetic analyses. Methods used for sequence analysis must be reported in full with citations and software and parameter values (even if only default values were used) in a separate section of Methods entitled "Phylogenetic Analysis". Please note that CLUSTAL does not produce an acceptable phylogeny; use a true phylogenetic analysis program (e.g., PHYLIP, MEGA, MR. BAYES). Alignments used to produce phylogenies should be produced with an appropriate alignment program (e.g., CLUSTAL), then manually adjusted to optimize alignments. Alignments must be provided as a Supplementary Table or Figure (preferably as a .doc file). Statistical support for nodes in phylogenetic tree figures must be reported (e.g., posterior probabilities or bootstrap values from a minimum of 1000 trials). Authors are encouraged to consult with an expert in molecular phylogenetics if they do not have such expertise themselves.

Accession numbers. Novel nucleotide and amino acid sequences must be deposited in a public repository such as the GenBank database (http://www.ncbi.nlm.nih.gov/). Accession numbers for genes must be specific for each gene; accession numbers for BAC clones or chromosomes are not acceptable substitutes. In the case of Arabidopsis, the AGI locus identifier ("At number") must be provided for each gene described (see http://www.arabidopsis.org). If a new function or mutation is found to be associated with a previously known DNA sequence (i.e., an existing GenBank entry), authors are encouraged to create a new GenBank entry in order to link the sequence and the gene symbol/function in the database. In the case of (partially or completely) sequenced vectors and constructs, accession numbers should be provided. All data necessary to validate protein structure determinations, including x-ray amplitudes and phases and the derived atomic coordinates, should be submitted to the Protein Data Bank (http://www.rcsb.org/pdb).

Accession numbers should be provided as the last paragraph of Methods (just before Acknowledgements) with the heading "Accession Numbers" for any genes or new sequence data discussed in the article. Insert the following statement and provide accession numbers: "Sequence data from this article can be found in the EMBL/GenBank data libraries under accession number(s) XX000000." In the case of Arabidopsis, the AGI locus identifier ("At number") must be provided for each gene described (see http://www.arabidopsis.org). If a list of accession numbers is provided in a table or figure, that can be stated in this section, rather than listing all of the numbers. Accession numbers must also be provided for any supplementary data that is placed in a permanent public repository (e.g., GEO http://www.ncbi.nlm.nih.gov/geo, Array-Express http://www.ebi.ac.uk/arrayexpress, or Protein Data Bank (http://www.rcsb.org/pdb)). If an accession number has not been assigned at the time of submission, please use Xs as placeholders to be updated later. In general, accession numbers should be provided only in the Methods, not elsewhere in the manuscript, unless needed for clarity.

Supplementary Data
We encourage authors to include all necessary data in the manuscript body. If large data sets are necessary and cannot be accommodated in the text body, supplementary data can be submitted according to the instructions for Supplementary Data Submission.

Figure legends
Figure legends should be concise and should not repeat information presented in the text. Figure numbers should be given in Arabic numerals and figure parts in upper case letters (eg 1A, 1B).
Include:
• all symbols and abbreviations that are used in the figure
• bar graph error bars and sample sizes
• scale, unless already indicated in the picture
Accession numbers should not be included in figure legends.
A separate typewritten, double-spaced list of legends of all figures must be supplied and included in the text file. Please be aware that figure legends are used by search engines for figure searc

References
You can download the current reference style for Molecular Plant from EndNote's website.

Cite references in the text by name and date of publication and not by number. List only articles that are published or in press. Cite in the text all unpublished results, including personal communications and submitted manuscripts (for example, R. Goldberg and K. Jofuku, unpublished results). A permission letter from each person cited as a personal communication will be required upon acceptance. Permission is also required from the authors of unpublished information cited in the text if those authors are different from the article's authors. Citations for web sites (other than for primary literature) should be handled parenthetically in the text and not included in the reference list. Authors should test all URLs and links.

It is expected that all cited publications have been read and determined to be appropriate by the authors, not merely identified by database searches. Reference to specific results should be to original research articles, not to more recent articles or reviews.

References should contain complete titles and inclusive page numbers. If you are citing an article that only exists as an online pre-issue version, use the ‘doi’ (unique identifying number) and publication date, as follows:

Author, A.B., and Author, B.B. (2007). Title of article. Molecular Plant Advance Access published March 5, 2003, doi:10.1093/mplant/msg013

The ‘doi’ is the long number typically given at the end of the reference in the online contents.

Authors are expected to proofread every citation in their reference list against the PDF or photocopy of the cited work so that the reference list is accurate with respect to spellings, symbols, italics, subscripts/superscripts, and accents.

Back to top

Figures

Figures should be self-explanatory and should provide enough information to be understood independently from the text. Figures should be sized to fit in a single column or across a page; group figures to fill the page wherever possible. Use the same fonts for all figures. Parts of composite figures should be labelled with lower case letters. Wording in figures must match the rest of the manuscript for capitalization, italics, and use of symbols. If labels contain typographic errors or inconsistencies, the author will be asked to upload corrected figures.

For gel blots, submit combination figures in which the labels and photographs or autoradiographs are composite images. In general, smaller gel images look neater than larger ones. Format sequence data to occupy one column for shorter sequences and two columns for longer sequences. Make sure that the fonts in sequences are easily readable, especially if sections are highlighted to display conserved or structural features.

Resolution. The minimum resolution for the figures is 300 dpi (dots per inch) for tone or colour, 1200 dpi for line art at approximately the correct size for publication.

Colour figures should be CMYK (Cyan-Magenta-Yellow-Black). Images which do not fit within 8.5 by 11 inches, or 19.75 x 25 centimeters, will be resized to fit those dimensions at 300 dpi.

File size. Please keep file size as small as possible. Large file sizes (30 MB or greater) may occasionally be needed, but should be avoided if possible. Please do not use any compression such as WinZip or STF. For TIFF image files, use LZW lossless compression, which has no quality loss due to compression.

Color figures. Colour figures should be converted to CMYK (Cyan-Magenta-Yellow-Black). "Adobe (1998)" should be selected as the ICC profile to ensure that we can reproduce the color accurately. RGB figures will be converted to CMYK on receipt, resulting in slight colour changes, therefore authors should convert before submission so that any adjustment in contrast is made at this stage to the author's satisfaction.

Observe the following guidelines to ensure that all readers, reviewers, and editors will be able to comprehend your data:
• In fluorescent double-staining micrographs and DNA chips, use magenta and green instead of red and green.
• For micrographs with triple or more channels, additionally show either a grayscale image of each channel, or the combination of the two most important channels in magenta and green.
• For graphs and line drawings, label elements on the graph itself rather than making a separate color-coded key.
• Do not try to convey information in color only, but use BOTH color and shape (solid and dotted lines, different symbols, various hatchings, etc.; however, avoid pattern fills if creating PowerPoint files). For more information, see the following website: http://jfly.iam.u-tokyo.ac.jp/color/.

Back to top

Cover Submissions

Each cover of Molecular Plant features an image representative of an article published in that issue. Authors who wish to have an image considered for the cover should upload the image as an additional supplementary file along with a separate text file that includes a brief one-paragraph description of the image, and indicate on the checklist provided at acceptance that a cover candidate has been submitted. If an author does not hold the copyright for a submitted image, they are responsible for obtaining the necessary permission to use the image in Molecular Plant.

Peer Review

Members of the editorial board will evaluate all manuscripts upon submission to determine whether they are appropriate for evaluation by expert outside reviewers. Decisions will be made as rapidly as possible, and the journal strives to return reviewers' comments to authors within four weeks whenever possible. If revision is requested, the editorial board will evaluate revised manuscripts and determine whether outside review is required. The board normally will consider only one revised manuscript, and this manuscript must be submitted within 1 month unless an extension is granted. In the case that extensive revision including additional experimentation is required, journal policy is to decline the manuscript, but editors may choose to encourage resubmission. Resubmissions are subject to the full review process. It is the goal of the journal to send authors a first decision within four weeks of submission and to publish manuscripts online within four weeks of final acceptance, but this can only be achieved if the original submission meets all journal requirements.

Proofs

The journal typesetter will deliver electronic page proofs to the corresponding author. The printer will notify the author via e-mail to retrieve page proofs. The author will have access to a PDF file, which will contain PDF pages (with figures and tables), a high-resolution PDF file of the images only, and a reprint order form. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Notes added in proof will be sent to the editor assigned to the manuscript prior to publication and will be reviewed for appropriate content and wording. Authors will receive proofs approximately 3 to 4 weeks after final acceptance of the manuscript. Because of the tight publication schedule, authors must relay all additions and corrections to Oxford Journals by e-mail within 24 hours of receipt of the proofs. Failure to act promptly to approve the page proofs may delay publication of the manuscript.

Fees and Charges

There are no page charges for publishing in Molecular Plant, and color figures that editors agree are essential will also be free of charge. Authors may need to justify that the color figure is essential for interpreting the results presented in the manuscript.

All papers in Molecular Plant are available free of charge to all readers during 2007 and 2008.

Reprints

The publishers supply the URL upon electronic publication. Offprint order forms are available to purchase printed offprints, however, all must be completed and returned with the proofs to Oxford University Press. Late orders submitted after the journal is printed are subject to increased prices.

Back to top

Policies

Author self-archiving/public access policy For information about this journal's policy, please visit our Author Self-Archiving policy page. It is a condition of publication in the Journal that authors grant an exclusive license to the Institute of Plant Physiology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and the Chinese Society for Plant Physiology. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. Authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and Oxford University Press is notified in writing and in advance.

Conflict of interest Molecular Plant policy requires that each author reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?

Ethics Molecular Plant is a member of the Committee on Publication Ethics (COPE), and strives to adhere to its code of conduct and guidelines. Authors are encouraged to consult http://www.publicationethics.org.uk/guidelines for more information.

Materials Distribution Policy Publication in Molecular Plant implies that the authors agree to provide materials that are integral to the results presented in the article, including whatever would be necessary for a skilled investigator to verify or replicate the claims. Authors are generally expected to take advantage of public repositories or commercial vendors to the extent possible. Authors should refer to the Materials Distribution Policy in these instructions for explanation of the journal's expectations of authors and requestors.
Further information.

Funding

Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgements' section.

The following rules should be followed:

An example is given here: ‘This work was supported by the National Institutes of Health [AA123456 to C.S., BB765432 to M.H.]; and the Alcohol & Education Research Council [hfygr667789].

Licence to Publish

Authors submitting manuscripts do so on the understanding that the work has not been published previously and, should it be accepted for publication, that the author(s) obtain the necessary permission to use material already protected by copyright. It is a condition of publication in the Journal that authors grant an exclusive licence to Oxford University Press. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. Licence to Publish forms will be forwarded to the author(s) following acceptance of the typescript for publication. Alternatively, to download a copy of the licence to publish form, please click here.

Back to top